Oman vs Zimbabwe: Cause of death, by non-communicable diseases, ages 60+, female
Oman
66.6%
in 2021
Zimbabwe
66.9%
in 2021
Oman rank
140th
Zimbabwe rank
139th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Oman
- Zimbabwe
How they compare
Zimbabwe currently reports 66.9% against 66.6% in Oman, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Oman ahead.
Oman ranks 140th and Zimbabwe ranks 139th of 185 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.2% | 60.4% | 31.7% | Oman |
| 2010s | 92.6% | 76.1% | 16.4% | Oman |
| 2020s | 73.3% | 71.9% | 1.3% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Oman or Zimbabwe?
- Zimbabwe, at 66.9% against 66.6% in Oman as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Oman and Zimbabwe?
- 0.3%, with Zimbabwe ahead.
- How many years of comparable data are there for Oman and Zimbabwe?
- 6 years are reported by both, from 2000 to 2021.
- How do Oman and Zimbabwe rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Oman ranks 140th and Zimbabwe ranks 139th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.